| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 141,895 | 218 |
| Effect of foreign exchange rates on cash and cash equivalents | 6 | 5 |
| Net decrease in cash and cash equivalents | -3,220 | -1,264 |
| Cash and cash equivalents at beginning of period | 44,252 | - |
| Cash and cash equivalents at end of period | 41,032 | - |
NEKTAR THERAPEUTICS (NKTR)
NEKTAR THERAPEUTICS (NKTR)